Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
49
TERN Quote, Financials, Valuation and Earnings
Last price:
$5.60
Seasonality move
:
22.63%
Day range:
$5.07 - $5.29
52-week range:
$1.87 - $11.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.41x
Volume:
830.4K
Avg. volume:
936.6K
1-year change:
-45.67%
Market cap:
$460.3M
Revenue:
--
EPS (TTM):
-$1.09
Earnings Data
Next earnings date for TERN
Aug 05
2025
Most recent earnings per share
-$0.26
Beat by $0.01
(May 8/2025)
Consensus Estimate
-$0.27
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TERN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.30 | -- |
| 08/05/2025 | Q2 | -- | -- | -- | -$0.29 | -- |
| 05/08/2025 | Q1 | -- | -- | -$0.26 | -$0.27 | $0.01 |
| 03/20/2025 | Q4 | -- | -- | -$0.24 | -$0.30 | $0.06 |
| 11/12/2024 | Q3 | -- | -- | -$0.28 | -$0.32 | $0.04 |
| 08/05/2024 | Q2 | -- | -- | -$0.31 | -$0.34 | $0.03 |
| 05/13/2024 | Q1 | -- | -- | -$0.30 | -$0.35 | $0.05 |
| 03/14/2024 | Q4 | -- | -- | -$0.29 | -$0.29 | $0.00 |
| 11/14/2023 | Q3 | -- | -- | -$0.42 | -$0.31 | -$0.11 |
| 08/08/2023 | Q2 | -- | -- | -$0.25 | -$0.33 | $0.08 |
| 05/15/2023 | Q1 | -- | -- | -$0.31 | -- | -- |
| 03/27/2023 | Q4 | -- | -- | -$0.29 | -- | -- |
| 11/09/2022 | Q3 | -- | -- | -$0.44 | -- | -- |
| 08/08/2022 | Q2 | -- | -- | -$0.55 | -- | -- |
| 05/16/2022 | Q1 | -- | -- | -$0.55 | -- | -- |
| 03/03/2022 | Q4 | -- | $1M | -$0.56 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$0.47 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$0.43 | -- | -- |
| 05/14/2021 | Q1 | -- | -- | -$0.88 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | $0.03 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.48 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.40 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.38 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.41 | -- | -- |
Terns Pharmaceuticals Earnings Questions
-
How Much did Terns Pharmaceuticals Generate in Revenue Last Quarter?
Terns Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Terns Pharmaceuticals Beat Earnings Last Quarter?
Terns Pharmaceuticals announced earnings per share of -$0.26 which represents a beat of analyst forecast a -$0.27 per share.
-
Is Terns Pharmaceuticals Profitable?
Terns Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Terns Pharmaceuticals EPS Next Year?
Terns Pharmaceuticals's earnings are forecast to decrease from -$1.12 per share to -$1.20 per share next year representing a decrease of -6.74%.
-
When is Terns Pharmaceuticals's Earnings Date?
Terns Pharmaceuticals's next earnings date is August 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
